Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 28% ± 1% | |
glutamatergic neuron | 3 studies | 40% ± 7% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1377.56 | 459 / 459 | 97% | 5.44 | 1081 / 1118 |
esophagus | 100% | 756.36 | 1442 / 1445 | 97% | 7.38 | 177 / 183 |
prostate | 100% | 1145.33 | 245 / 245 | 96% | 6.64 | 484 / 502 |
lung | 100% | 900.50 | 576 / 578 | 97% | 7.04 | 1117 / 1155 |
kidney | 100% | 1036.60 | 89 / 89 | 96% | 9.17 | 867 / 901 |
pancreas | 99% | 562.47 | 326 / 328 | 97% | 5.80 | 172 / 178 |
bladder | 100% | 978.24 | 21 / 21 | 95% | 5.67 | 481 / 504 |
liver | 100% | 720.04 | 226 / 226 | 95% | 7.02 | 387 / 406 |
uterus | 100% | 1204.56 | 170 / 170 | 95% | 6.11 | 437 / 459 |
thymus | 100% | 1311.39 | 653 / 653 | 95% | 5.54 | 576 / 605 |
skin | 100% | 1101.34 | 1805 / 1809 | 95% | 7.94 | 450 / 472 |
brain | 94% | 436.75 | 2482 / 2642 | 100% | 12.04 | 702 / 705 |
ovary | 100% | 1335.29 | 180 / 180 | 93% | 4.72 | 400 / 430 |
adrenal gland | 100% | 1008.01 | 258 / 258 | 91% | 4.78 | 210 / 230 |
stomach | 99% | 651.16 | 355 / 359 | 91% | 4.28 | 259 / 286 |
intestine | 100% | 828.18 | 965 / 966 | 89% | 4.21 | 470 / 527 |
adipose | 100% | 1421.93 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1180.01 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.01 | 1 / 1 |
blood vessel | 100% | 1445.49 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 92% | 600.07 | 795 / 861 | 0% | 0 | 0 / 0 |
muscle | 91% | 386.19 | 733 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 7.34 | 70 / 80 |
lymph node | 0% | 0 | 0 / 0 | 86% | 6.06 | 25 / 29 |
tonsil | 0% | 0 | 0 / 0 | 84% | 4.32 | 38 / 45 |
peripheral blood | 35% | 254.35 | 322 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016836 | Molecular function | hydro-lyase activity |
GO_0050346 | Molecular function | trans-L-3-hydroxyproline dehydratase activity |
GO_0018112 | Molecular function | proline racemase activity |
Gene name | L3HYPDH |
Protein name | trans-L-3-hydroxyproline dehydratase (EC 4.2.1.77) Trans-3-hydroxy-L-proline dehydratase (EC 4.2.1.77) (Trans-L-3-hydroxyproline dehydratase) |
Synonyms | C14orf149 |
Description | FUNCTION: Catalyzes the dehydration of trans-3-hydroxy-L-proline to Delta(1)-pyrroline-2-carboxylate (Pyr2C). May be required to degrade trans-3-hydroxy-L-proline from the diet and originating from the degradation of proteins such as collagen-IV that contain it. . |
Accessions | ENST00000481608.1 ENST00000487285.5 ENST00000247194.9 D6RC46 Q96EM0 E9PKK7 |